Insilico Bench | Insilico Medicine

Insilico's Proprietary AI Benchmarks

Proprietary benchmarks developed by Insilico Medicine to evaluate AI systems across the drug discovery pipeline — from target identification to clinical development. A research initiative by Insilico Medicine.

Insilico Bench Benchmarks Explorer

Interactive exploration of benchmarks across Biology, Chemistry, Materials, and Longevity. Browse and compare model performance with built-in visualizations.

Models Ranked

16 of 17 total Models Ranked
198 of 203 total Benchmarks
5 active Categories

Top Model: GPT 5.5
Insilico score: 66.4

Included benchmarks (198)

Ranked Table

# Model Insilico Score Biology Affinity and Binding Chemical Synthesis ADMET, PK & Safety Clinical Trials
1 GPT 5.5 66.4 35 71 30 70 81
2 Claude Opus 4.8 58.6 30 57 26 69 78
3 Claude Opus 4.6 58.5 59 62 9 63 72
4 Claude Opus 4.5 57.9 63 59 9 66 73
5 Claude Opus 4.7 56.9 70 12 70
6 DeepSeek v3.2 56.3 56 62 1 59 68
7 Claude Sonnet 4.5 55.9 61 62 6 62 59
8 GPT 5.2 55.1 57 62 4 61 53
9 Grok 4.1 55.0 51 61 14 59 60
10 Kimi K2.5 52.8 58 56 9 61 64
... ... ... ... ... ... ... ...

Insilico's Proprietary AI Evaluation Suite

Insilico Bench is Insilico Medicine's proprietary benchmarking platform, built to rigorously evaluate AI models on real-world drug discovery tasks using internal datasets and domain expertise.

Proprietary Data

Benchmarks built on Insilico's internal drug discovery datasets and pipelines.

LLM Evaluation

Comprehensive testing of large language models on domain-specific tasks.

Transparent Metrics

Clear, reproducible evaluation metrics with public leaderboards.

Industry-Proven

Grounded in Insilico Medicine's track record of AI-driven drug candidates in clinical trials.